IRIS UniCatt

Cingolani, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.383
AS - Asia 3.272
EU - Europa 3.173
SA - Sud America 736
AF - Africa 141
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.186
SG - Singapore 1.460
IT - Italia 729
CN - Cina 678
BR - Brasile 612
DE - Germania 609
SE - Svezia 502
FR - Francia 335
VN - Vietnam 327
GB - Regno Unito 208
IE - Irlanda 142
UA - Ucraina 139
FI - Finlandia 123
IN - India 117
CA - Canada 106
JP - Giappone 95
HK - Hong Kong 93
ID - Indonesia 92
PL - Polonia 85
RU - Federazione Russa 71
BD - Bangladesh 61
MX - Messico 56
NL - Olanda 56
TR - Turchia 53
AR - Argentina 49
PK - Pakistan 37
AT - Austria 36
IQ - Iraq 35
BE - Belgio 33
SA - Arabia Saudita 31
PH - Filippine 28
ZA - Sudafrica 27
IR - Iran 26
KR - Corea 26
AU - Australia 24
EG - Egitto 19
ES - Italia 19
EC - Ecuador 18
MA - Marocco 18
TN - Tunisia 18
KE - Kenya 15
VE - Venezuela 15
CH - Svizzera 13
LT - Lituania 13
MY - Malesia 13
AE - Emirati Arabi Uniti 12
CO - Colombia 12
JO - Giordania 12
UZ - Uzbekistan 12
CI - Costa d'Avorio 11
CL - Cile 10
CZ - Repubblica Ceca 9
IL - Israele 9
NG - Nigeria 9
NP - Nepal 8
PT - Portogallo 8
PE - Perù 7
KG - Kirghizistan 6
PY - Paraguay 6
RO - Romania 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EE - Estonia 5
GR - Grecia 5
LV - Lettonia 5
UY - Uruguay 5
BG - Bulgaria 4
ET - Etiopia 4
EU - Europa 4
JM - Giamaica 4
MM - Myanmar 4
NI - Nicaragua 4
TH - Thailandia 4
AO - Angola 3
BB - Barbados 3
BZ - Belize 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
SD - Sudan 3
BW - Botswana 2
BY - Bielorussia 2
CM - Camerun 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PA - Panama 2
TJ - Tagikistan 2
VA - Santa Sede (Città del Vaticano) 2
Totale 11.716
Salva come PNG Salva come JPEG
Città #
Singapore 769
Chandler 486
Ashburn 470
San Jose 458
New York 182
Rome 182
Dublin 139
Beijing 122
Ho Chi Minh City 121
Dallas 112
Los Angeles 94
Milan 91
Jacksonville 90
Tokyo 89
Lauterbourg 86
Jakarta 82
San Mateo 80
Hanoi 78
The Dalles 78
Chicago 75
Hefei 74
Hong Kong 74
Nanjing 67
Ann Arbor 61
São Paulo 58
Wilmington 58
Helsinki 54
Boston 52
Munich 52
Redmond 51
Frankfurt am Main 50
Dearborn 46
Princeton 46
St Louis 46
Council Bluffs 45
Kraków 45
Moscow 40
London 38
Marseille 35
Boardman 34
Bremen 34
North Bergen 34
Orem 34
Houston 33
Nuremberg 31
Amsterdam 29
Brussels 29
Cattolica 28
Santa Clara 27
Woodbridge 26
Kent 25
Montreal 24
Nürnberg 24
Buffalo 23
Nanchang 23
Rio de Janeiro 23
Warsaw 23
Izmir 22
Ottawa 22
Da Nang 21
Paris 20
Redwood City 20
Seoul 20
Atlanta 19
Brooklyn 19
Guangzhou 19
Lappeenranta 19
Turku 19
Lawrence 18
San Francisco 18
Seattle 18
Fairfield 17
Johannesburg 17
Vienna 17
Düsseldorf 16
Haiphong 16
Lancaster 16
Phoenix 16
Stockholm 16
Baghdad 15
Denver 15
Kunming 15
Pune 15
Mexico City 14
Norwalk 14
Poplar 14
Tianjin 14
Chennai 13
Dammam 13
Lahore 13
Toronto 13
Amman 12
Augusta 12
Dhaka 12
Fremont 12
Washington 12
Abidjan 11
Belo Horizonte 11
Cairo 11
Istanbul 11
Totale 6.057
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 527
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 316
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 269
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 234
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 231
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 227
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 212
Malnutrition in COVID-19 survivors: prevalence and risk factors 197
Plasma levels of Interleukin-6 and Interleukin-10 in preterm neonates evaluated for sepsis 197
Residual respiratory impairment after COVID-19 pneumonia 193
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 189
COVID-19 atypical Parsonage-Turner syndrome: a case report 175
Residual respiratory impairment after COVID-19 pneumonia 175
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 170
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 168
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 164
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 163
Sarilumab use in severe SARS-CoV-2 pneumonia 162
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 162
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 160
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 158
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure 157
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 156
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis 155
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 152
Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review. 145
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 140
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital 140
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 139
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 137
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 136
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 136
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients 135
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 135
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 133
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 132
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 132
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 129
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 128
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 126
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 125
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy 124
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 123
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 121
Interpretation systems for genotypic drug resistance of HIV-1 120
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 117
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 117
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study 116
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 116
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 114
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 114
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry 111
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Clinical implications of HIV-1 drug resistance in the neurological compartment 108
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy 107
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 107
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 107
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 104
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 102
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 101
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022 99
[Treating HIV disease: back to the patient?] 99
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure. 98
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 96
Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023: preliminary investigation 96
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 96
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition 94
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 92
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective 91
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials 91
Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin 88
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 88
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting 86
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: Data from the ICONA foundation study group, years 1997-2013 83
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 82
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 78
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 75
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 75
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 73
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 73
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 70
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 68
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 68
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 58
Is the rate of virological failure to cART continuing to decline in recent calendar years? 54
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study 47
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments 44
Prognostic Value of Procalcitonin in Febrile People Living with Human Immunodeficiency Virus (PLWH) Admitted to the Emergency Department 31
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 29
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients 1
Totale 11.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.865
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022669 53 44 14 41 32 20 12 99 33 54 110 157
2022/20231.824 190 187 182 335 175 233 86 97 185 70 63 21
2023/2024929 42 198 37 52 40 167 67 36 22 61 83 124
2024/20252.069 36 52 126 102 144 95 138 92 321 192 393 378
2025/20264.820 654 202 384 594 762 273 741 247 388 406 154 15
Totale 11.912